The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Carboplatin in patients with metastatic castration-resistant prostate cancer harboring somatic or germline homologous recombination repair gene mutations: Phase II single-arm trial (CiPHeR).
 
Rishabh Jain
No Relationships to Disclose
 
Atul Batra
Stock and Other Ownership Interests - Caplin Point Laboratories; Glenmark; Laurus; Zydus Pharmaceuticals
Research Funding - Alkem Laboratories; Astellas Pharma; AstraZeneca
 
Akash Kumar
No Relationships to Disclose
 
Atul Sharma
Stock and Other Ownership Interests - DIVIS LAB; Dr Reddys Lab; GLENMARK (I); JYOTHI LAB; LAURUS LAB; SHILPA MEDICARE; ZYDUS WELLNESS; ZYDUSLIFESCIENCES
Honoraria - AstraZeneca; DR REDDYS LAB; Merck Serono; MSD Oncology; PFIZER INDIA LIMITED; Roche India; ZYDUS LIFE SCIENCES
Speakers' Bureau - Merck Serono; ZYDUS LIFESCIENCES
 
Ranjit Sahoo
No Relationships to Disclose
 
Aparna Sharma
No Relationships to Disclose
 
Amlesh Seth
No Relationships to Disclose
 
Brusabhanu Nayak
No Relationships to Disclose
 
Shamim Ahmed Shamim
No Relationships to Disclose
 
Seema Kaushal
No Relationships to Disclose
 
Haresh Kunhi Parambath
No Relationships to Disclose
 
Chandan Das
No Relationships to Disclose